Renal Causes of Simultaneous Hypokalemia, Hypomagnesemia, and Hypocalcemia
The primary renal causes of this electrolyte triad are inherited tubulopathies (Bartter syndrome and Gitelman syndrome), drug-induced tubular dysfunction (particularly calcineurin inhibitors, aminoglycosides, and proton pump inhibitors), and chronic tubulointerstitial nephropathies with renal magnesium wasting.
Inherited Tubulopathies
Bartter Syndrome
Bartter syndrome presents with hypokalemia and metabolic alkalosis, with mild hypomagnesemia noted particularly in Type 1 1. The syndrome is characterized by:
- Polyuria and hypochloremia
- Elevated fractional chloride excretion (>0.5%)
- High or variable calcium excretion (distinguishing it from Gitelman)
- Presentation ranging from prenatal (with polyhydramnios) to adolescence
Gitelman Syndrome
Gitelman syndrome is the classic cause of this electrolyte triad in adults, characterized by 2:
- Renal potassium and magnesium wasting
- Hypocalciuria (strikingly low 24-hour urinary calcium despite normocalcemia)
- Defect in the distal convoluted tubule
- Often presents in adolescence or adulthood
- Normal distal fractional chloride reabsorption during water load but reduced during hypotonic saline infusion
The hypocalciuria distinguishes Gitelman from Bartter syndrome and is a key diagnostic feature 1, 2.
Drug-Induced Renal Wasting
Calcineurin Inhibitors (Cyclosporine, Tacrolimus)
These drugs inhibit magnesium reabsorption in the distal convoluted tubule via effects on the TRPM6 transporter 3. The mechanism creates:
- Inappropriately high fractional excretion of magnesium relative to serum levels
- Secondary hypocalcemia and hypokalemia that normalize with magnesium replacement alone
- Common in renal transplant recipients requiring periodic monitoring
Aminoglycosides (Gentamicin)
Gentamicin causes renal wasting of magnesium and potassium, leading to the complete triad 4:
- Inappropriately low parathyroid hormone levels during hypocalcemia
- Resolves with drug discontinuation
- Requires monitoring of calcium, magnesium, and potassium during therapy
Proton Pump Inhibitors
Long-term PPI use (particularly omeprazole) causes 5:
- Magnesium malabsorption leading to hypomagnesemia
- Secondary hypocalcemia via inhibition of PTH secretion
- Hypokalaemia through renal mechanisms
- Can cause life-threatening complications including rhabdomyolysis
Chronic Tubulointerstitial Nephropathies
In patients with chronic interstitial nephropathy, chronic renal losses of magnesium produce hypomagnesemic hypocalcemia 6. Key features include:
- Five of six patients in one series had chronic interstitial nephropathy with renal magnesium wasting
- Elevated PTH levels in absolute terms, but inappropriate to correct hypocalcemia
- Variable PTH response after magnesium replacement (increased in some, not in others)
- Magnesium administration increases calcium levels in all cases
Diagnostic Approach
Distinguish Renal from Extrarenal Losses
- Fractional chloride excretion >0.5% suggests renal salt wasting 1
- Urinary magnesium excretion: inappropriate magnesiuria despite hypomagnesemia indicates renal wasting 7
- All patients with this triad exhibit renal potassium and calcium wasting despite hypokalemia and hypocalcemia 7
Key Laboratory Patterns
The syndrome typically presents with 7:
- Inappropriate kaliuresis despite hypokalemia
- Inappropriate magnesiuria despite hypomagnesemia
- Renal calcium wasting despite hypocalcemia
- Inappropriately low or suppressed PTH levels during hypocalcemia 4, 8
- Often coexisting acid-base disorders (respiratory or metabolic alkalosis)
Critical Clinical Pitfall
Always replace magnesium FIRST before attempting to correct calcium or potassium 8. Hypomagnesemia causes:
- Suppression of PTH secretion
- End-organ resistance to PTH
- Renal potassium wasting
Replacing magnesium alone often corrects the hypoparathyroidism and normalizes calcium and potassium levels without additional replacement therapy 3, 8. Attempting to correct calcium or potassium without addressing magnesium deficiency will be ineffective and potentially dangerous.
Common Causes by Clinical Context
Alcoholism and cisplatin administration are the most common causes of the complete triad in hospitalized patients 7, though these involve both renal and extrarenal mechanisms. Pure renal causes require:
- Medication history (calcineurin inhibitors, aminoglycosides, PPIs)
- Assessment for inherited tubulopathies (especially in younger patients with hypocalciuria)
- Evaluation for chronic tubulointerstitial disease
In renal transplant patients on calcineurin inhibitors, periodic monitoring of magnesium is essential to prevent this complication 3.